About Stellixir Biotech
Stellixir Biotech is a company based in Bengaluru (India) by Janardhana PB. It operates as a B2B. Stellixir Biotech offers products and services including In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services. Stellixir Biotech operates in a competitive market with competitors including Cellply, Reaction Biology, ImmunoSCAPE, Lucid Scientific and Kiyatec, among others.
- Headquarter Bengaluru, India
- Founders Janardhana PB
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Stellixir Biotech Private Limited
- Date of Incorporation 10 Sep, 2014
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$86.7 K (USD)155.6as on Mar 31, 2022
-
Net Profit
$24.08 K (USD)291.29as on Mar 31, 2022
-
EBITDA
$33.9 K (USD)624.73as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Stellixir Biotech
Stellixir Biotech offers a comprehensive portfolio of products and services, including In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services.
Customized services for early drug discovery using cell-based models.
Evaluates drug toxicity across various organ systems.
Offers isolation and characterization for degenerative disease studies.
Funding Insights of Stellixir Biotech
Detailed funding history for Stellixir Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Stellixir Biotech
Investment portfolio details for Stellixir Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Stellixir Biotech
Detailed financials for Stellixir Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Stellixir Biotech Comparisons
Peer comparison for Stellixir Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Stellixir Biotech
Stellixir Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellply, Reaction Biology, ImmunoSCAPE, Lucid Scientific and Kiyatec, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in-vitro diagnostic products for the detection of cancer
|
|
| Locked | Locked | Locked |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| Locked | Locked | Locked |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| Locked | Locked | Locked |
Real-time cell analyzers are developed for oxygen consumption monitoring.
|
|
| Locked | Locked | Locked |
Kiyatec is focused on revolutionizing cancer care through predictive platforms.
|
|
| Locked | Locked | Locked |
Cell-based assays for drug discovery are developed via CMOS platform.
|
Detailed competitors of Stellixir Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Stellixir Biotech
Complete news archive for Stellixir Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stellixir Biotech
Stellixir Biotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Janardhana PB is the current CEO of Stellixir Biotech. They have also founded this company.
Annual revenue of Stellixir Biotech is $86.7K as on Mar 31, 2022.
Stellixir Biotech Pvt. Ltd., based in Bangalore, India, is a preclinical contract research organization specializing in in vitro services for drug discovery, toxicology, and stem cell research. They deliver customized solutions for various diseases, including cardiovascular and oncology, using advanced facilities and regulatory-compliant methods. Serving biotech, pharma, and academic clients, they focus on innovative, reliable preclinical testing to support early drug development.
Stellixir Biotech's top competitors include ImmunoSCAPE, CytoTronics and Kiyatec.
Stellixir Biotech offers In Vitro Disease Modelling, Toxicology and Safety Assessment, and Stem Cell Research Services.